The urgent need for better treatments for Guillain-Barré Syndrome
Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.
Yahoo Finance18d
New Survey Offers Detailed View of Short- and Long-Term Burden of Guillain-Barré Syndrome
CONSHOHOCKEN, Pa., Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today released new survey data illustrating how people with Guillain-Barré Syndrome experience this life ...
Albuquerque Journal24d
Bob D. Kitts Bobbie Dean Kitts, born on February 23, 1940 in
In lieu of flowers, donations may be made to the Guillain-Barre Syndrome at the GBS/CIDP Foundation International, 375 East Elm Street, Suite 101, Conshohocken, PA 19428. May his memory be a blessing.
Hosted on MSN16d
New Survey Sheds Light on Guillain-Barré Syndrome Challenges
CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with ...
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones
Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...
Fierce Pharma5d
Argenx's Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
Seeking Alpha18d
argenx SE (ARGX) Q4 2024 Earnings Call Transcript
These accomplishments have laid a robust foundation for our continued momentum ... a key driver of this growth in 2025 for both MG and CIDP. It is incredible to see the strong early adoption ...